Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriatic Erythroderma”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT01782937
What this trial is testing

An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 30
Post-approval studies (Phase 4)Study completedNCT04183881
What this trial is testing

Clinical Study of Brodalumab

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 138
Large-scale testing (Phase 3)Study completedNCT02052609
What this trial is testing

Clinical Study of KHK 4827

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 155
Large-scale testing (Phase 3)Study completedNCT01680159
What this trial is testing

A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis

Who this might be right for
Plaque PsoriasisPsoriatic ArthritisPustular Psoriasis (Excluding a Localized)+1 more
Tanabe Pharma Corporation 51
Not applicableUnknownNCT05144165
What this trial is testing

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Who this might be right for
PsoriasisPsoriasis PalmarisPsoriasis Inverse+8 more
Centre of Evidence of the French Society of Dermatology 30